Hyaluronidase[ (Wydase) ] Drug Information

Contains Hyaluronidase drug information and provides Hyaluronidase drug indication, contraindication, special concerns, side effects, overdose management and dosage
Search Drugs by Generic or Trade Name:
Browse Drugs by Generic Name:
[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z ]

Adjunct to promote absorption and dispersion of liquids and drugs, for hypodermoclysis, adjunct in urography to improve resorption of radiopaque agents, administration of local anesthetics. (Hyaluronidase can be added to primary drug solution or injected prior to administration of primary drug solution.)
Back to Top
Do not inject into acutely infected or cancerous areas.
Back to Top
Special Concerns:
Use with caution during lactation.
Back to Top
Side Effects:
Rarely, sensitivity reactions, including urticaria and anaphylaxis.
Back to Top
Overdose Management:
Symptoms: Local edema or urticaria, chills, erythema, dizziness, N&V, tachycardia, hypotension. Treatment: Discontinue and begin supportive treatment immediately. Epinephrine, corticosteroids, and antihistamines may be required to treat symptoms.
Back to Top
Drug Interactions:
No Available information
Back to Top
•SC Drug and fluid dispersion.

Adults and older children, usual: 150 units added to the injection solution.

SC urography.

(When IV injection cannot be used.) With client in prone position: 75 units SC over each scapula, followed by contrast medium in same site.


150 units, which facilitates absorption of 1,000 mL fluid (give at a rate no faster than would be used for IV infusion); pediatric, less than 3 years: volume of single clysis should be limited to 200 mL; premature infants, neonates: do not exceed 25 mL/kg/day given at a rate no greater than 2 mL/min.
Back to Top